Bend Bioscience
Bend, OR
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (10)
○ EMA GMP
○ MHRA GMP
Quick Facts: Bend Bioscience
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Bend, OR
- Modalities
- Spray Dried Dispersion (SDD), Amorphous Solid Dispersion (ASD), Particle Engineering, Oral Solid Dose, Multiparticulates, Modified Release, Small Molecule API
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Bend Bioscience
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSpray Dried Dispersion (SDD), Amorphous Solid Dispersion (ASD), Particle Engineering, Oral Solid Dose, Multiparticulates, Modified Release, Small Molecule API
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (7 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press10 articles
Broad modality coverage (7 modalities)
Recent News 10 articles
Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc. - GlobeNewswire
CoreRx, Societal CDMO, and Bend Bioscience Unite Under the Bend Bioscience Brand to Provide World Class CDMO offering - PR Newswire
GHCC: Bend Bioscience expanding - 97.5 Glory FM
Meribel Pharma Solutions launches to take pharma services to new heights - Pharmafile
NovaQuest Private Equity Announces Investment In Bend Bioscience to Broaden CoreRx Offering - PR Newswire
Bend Bioscience’s Expanded Vision for Complex Drug Delivery - Contract Pharma
Owen Murray Tapped as CEO of Combined Bend Bioscience, CoreRx and Societal Entities - Contract Pharma
Bend Bioscience adds commercial spray drying facility to Georgia site - Pharmafile
Bioscience Company Announces Plans for Bend-Based Lab - oregonbusiness.com
Modified Release Dosage Forms: Giving New Life to Drugs - Contract Pharma
Frequently Asked Questions About Bend Bioscience
What is Bend Bioscience's CDMO Signal Score?
Bend Bioscience has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Bend Bioscience for a manufacturing program?
Use the free AI matchmaker to compare Bend Bioscience against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Codis
St. Louis, MO (US HQ); Haverhill, UK (EU operations)
Spray Dried Dispersion (SDD), Amorphous Solid Dispersion (ASD), Particle Engineering, Oral Solid Dose, Finished Dose Manufacturing, Commercial-Scale Spray Drying
Serán Bioscience
Bend, OR
Small Molecule (Oral Solid Dose), Spray Dried Dispersion (SDD), Hot Melt Extrusion (HME), Nano-milling / Nanoparticulate, Fluid Bed Processing, Particle Engineering, Pulmonary / Inhaled Particulates, Nasal Drug Delivery, Finished Dose (tablets, capsules, OPCs, powder-in-bottle)
Sun Pharmaceutical Industries Ltd.
Mumbai, India
Small Molecule API, Oral Solid Dose, Sterile Injectables, Specialty Generics, Novel Chemical Entities (NCE) via CRAMS, Biologics (via CMO partnerships), Specialty/Innovative Medicines
Olon Group
Rodano (Milan), Italy
Small Molecule API, HPAPI / Cytotoxics, Microbial Fermentation, Mammalian Cell Culture, Recombinant Proteins / Enzymes, Biologics (mAbs), ADC (end-to-end bioconjugation), Oligonucleotide / Peptide, Chemical Synthesis, Semi-Synthesis
Fermion (Orion Group)
Espoo, Finland
Small Molecule API, HPAPI, Semi-solid drug product (creams, gels, ointments), Hormonal products